Medpace (MEDP) — insider trading
Health Care · NASDAQ
Medpace (MEDP) has 78 reported SEC Form 4 insider transactions in our data, including 32 open-market sales among the most recent 78 (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | McCarthy Cornelius P. III | Director | Option exercise / conversion (derivative) | 28 | — | $0 | Form 4 |
| 2026-09-30 | McCarthy Cornelius P. III | Director | Option exercise / conversion | 28 | — | — | Form 4 |
| 2026-09-30 | Kraft Robert O. | Director | Option exercise / conversion (derivative) | 32 | — | $0 | Form 4 |
| 2026-09-30 | Kraft Robert O. | Director | Option exercise / conversion | 32 | — | — | Form 4 |
| 2026-09-30 | Carley Brian T | Director | Option exercise / conversion (derivative) | 36 | — | $0 | Form 4 |
| 2026-09-30 | Carley Brian T | Director | Option exercise / conversion | 36 | — | — | Form 4 |
| 2026-09-30 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 21,966 | $625.47 | $13.74M | Form 4 |
| 2026-09-29 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 26,701 | $621.02 | $16.58M | Form 4 |
| 2026-09-28 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 2,410 | $620.07 | $1.49M | Form 4 |
| 2026-09-25 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 154 | $620.60 | $95.6K | Form 4 |
| 2026-09-24 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 27,833 | $621.33 | $17.29M | Form 4 |
| 2026-09-23 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 16,083 | $628.64 | $10.11M | Form 4 |
| 2026-09-22 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 49,018 | $628.11 | $30.79M | Form 4 |
| 2026-09-21 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 21,883 | $623.29 | $13.64M | Form 4 |
| 2026-09-17 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 10,880 | $620.40 | $6.75M | Form 4 |
| 2026-09-16 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 8,770 | $621.29 | $5.45M | Form 4 |
| 2026-09-15 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 15,971 | $620.84 | $9.92M | Form 4 |
| 2026-09-15 | BURWIG SUSAN E | Officer (Exec. VP, Operations) | Option exercise / conversion (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-09-15 | BURWIG SUSAN E | Officer (Exec. VP, Operations) | Option exercise / conversion | 3,000 | $166.73 | $500.2K | Form 4 |
| 2026-08-27 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 650 | $620.27 | $403.2K | Form 4 |
| 2026-08-26 | Kraft Robert O. | Director | Option exercise / conversion (derivative) | 3,858 | — | $0 | Form 4 |
| 2026-08-26 | Kraft Robert O. | Director | Open-market sale | 3,858 | $617.81 | $2.38M | Form 4 |
| 2026-08-26 | Kraft Robert O. | Director | Option exercise / conversion | 3,858 | $84.36 | $325.5K | Form 4 |
| 2026-08-26 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 4,000 | $620.03 | $2.48M | Form 4 |
| 2026-08-25 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 673 | $620.38 | $417.5K | Form 4 |
| 2026-08-24 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 1,983 | $620.23 | $1.23M | Form 4 |
| 2026-08-21 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 13,995 | $624.45 | $8.74M | Form 4 |
| 2026-08-20 | Brady Kevin M. | Officer (CFO & Treasurer) | Option exercise / conversion (derivative) | 3,400 | — | $0 | Form 4 |
| 2026-08-20 | Brady Kevin M. | Officer (CFO & Treasurer) | Open-market sale | 3,400 | $625.24 | $2.13M | Form 4 |
| 2026-08-20 | Brady Kevin M. | Officer (CFO & Treasurer) | Option exercise / conversion | 3,400 | $138.87 | $472.2K | Form 4 |
| 2026-08-20 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 27,174 | $618.79 | $16.81M | Form 4 |
| 2026-08-19 | DAVENPORT FRED B JR | Director | Option exercise / conversion (derivative) | 1,822 | — | $0 | Form 4 |
| 2026-08-19 | DAVENPORT FRED B JR | Director | Option exercise / conversion (derivative) | 3,858 | — | $0 | Form 4 |
| 2026-08-19 | DAVENPORT FRED B JR | Director | Option exercise / conversion (derivative) | 1,903 | — | $0 | Form 4 |
| 2026-08-19 | DAVENPORT FRED B JR | Director | Open-market sale | 7,283 | $606.15 | $4.41M | Form 4 |
| 2026-08-19 | DAVENPORT FRED B JR | Director | Option exercise / conversion | 1,822 | $164.68 | $300.0K | Form 4 |
| 2026-08-19 | DAVENPORT FRED B JR | Director | Option exercise / conversion | 3,858 | $84.36 | $325.5K | Form 4 |
| 2026-08-19 | DAVENPORT FRED B JR | Director | Option exercise / conversion | 1,903 | $133.87 | $254.8K | Form 4 |
| 2026-08-19 | Carley Brian T | Director | Open-market sale | 5,000 | $608.63 | $3.04M | Form 4 |
| 2026-08-19 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 15,609 | $606.47 | $9.47M | Form 4 |
| 2026-08-13 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 458 | $600.39 | $275.0K | Form 4 |
| 2026-08-12 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 11,366 | $601.53 | $6.84M | Form 4 |
| 2026-08-11 | McCarthy Cornelius P. III | Director | Open-market sale | 1,140 | $605.37 | $690.1K | Form 4 |
| 2026-08-11 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 17,610 | $605.11 | $10.66M | Form 4 |
| 2026-08-10 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 5,534 | $601.53 | $3.33M | Form 4 |
| 2026-08-07 | McCarthy Cornelius P. III | Director | Option exercise / conversion (derivative) | 3,858 | — | $0 | Form 4 |
| 2026-08-07 | McCarthy Cornelius P. III | Director | Open-market sale | 795 | $585.07 | $465.1K | Form 4 |
| 2026-08-07 | McCarthy Cornelius P. III | Director | Option exercise / conversion | 3,858 | $84.36 | $325.5K | Form 4 |
| 2026-07-28 | BURWIG SUSAN E | Officer (Exec. VP, Operations) | Open-market sale | 7,500 | $600.00 | $4.50M | Form 4 |
| 2026-07-28 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 3,510 | $600.01 | $2.11M | Form 4 |
| 2026-07-27 | Troendle August J. | Director, Officer (President & CEO), 10% owner | Open-market sale | 3,728 | $600.85 | $2.24M | Form 4 |
| 2026-06-30 | Carley Brian T | Director | Option exercise / conversion (derivative) | 36 | — | $0 | Form 4 |
| 2026-06-30 | Carley Brian T | Director | Option exercise / conversion | 36 | — | — | Form 4 |
| 2026-06-30 | Kraft Robert O. | Director | Option exercise / conversion (derivative) | 33 | — | $0 | Form 4 |
| 2026-06-30 | Kraft Robert O. | Director | Option exercise / conversion | 33 | — | — | Form 4 |
| 2026-06-30 | McCarthy Cornelius P. III | Director | Option exercise / conversion (derivative) | 28 | — | $0 | Form 4 |
| 2026-06-30 | McCarthy Cornelius P. III | Director | Option exercise / conversion | 28 | — | — | Form 4 |
| 2026-05-28 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Option exercise / conversion (derivative) | 16,349 | — | $0 | Form 4 |
| 2026-05-28 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Open-market sale | 16,349 | $450.00 | $7.36M | Form 4 |
| 2026-05-28 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Option exercise / conversion | 16,349 | $138.87 | $2.27M | Form 4 |
| 2026-05-15 | Carley Brian T | Director | Grant / award / vesting (derivative) | 1,110 | — | $0 | Form 4 |
| 2026-05-15 | DAVENPORT FRED B JR | Director | Grant / award / vesting (derivative) | 1,110 | — | $0 | Form 4 |
| 2026-05-15 | Gwadry-Sridhar Femida H. | Director | Grant / award / vesting (derivative) | 1,110 | — | $0 | Form 4 |
| 2026-05-15 | Kraft Robert O. | Director | Grant / award / vesting (derivative) | 1,110 | — | $0 | Form 4 |
| 2026-05-15 | McCarthy Cornelius P. III | Director | Grant / award / vesting (derivative) | 1,110 | — | $0 | Form 4 |
| 2026-05-15 | Zander Dani S. | Director | Grant / award / vesting (derivative) | 1,110 | — | $0 | Form 4 |
| 2026-04-24 | Brady Kevin M. | Officer (CFO & Treasurer) | Grant / award / vesting (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-04-24 | Brady Kevin M. | Officer (CFO & Treasurer) | Grant / award / vesting (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-04-24 | Brady Kevin M. | Officer (CFO & Treasurer) | Option exercise / conversion (derivative) | 7,000 | — | $0 | Form 4 |
| 2026-04-24 | Brady Kevin M. | Officer (CFO & Treasurer) | Option exercise / conversion | 7,000 | $138.87 | $972.1K | Form 4 |
| 2026-04-24 | BURWIG SUSAN E | Officer (Exec. VP, Operations) | Grant / award / vesting (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-04-24 | BURWIG SUSAN E | Officer (Exec. VP, Operations) | Grant / award / vesting (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-04-24 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Grant / award / vesting (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-04-24 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Grant / award / vesting (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-04-24 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Option exercise / conversion (derivative) | 3,500 | — | $0 | Form 4 |
| 2026-04-24 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Option exercise / conversion | 3,500 | $138.87 | $486.0K | Form 4 |
| 2026-04-24 | Troendle August J. | Director, Officer (CEO), 10% owner | Grant / award / vesting (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-04-24 | Troendle August J. | Director, Officer (CEO), 10% owner | Grant / award / vesting (derivative) | 20,000 | — | $0 | Form 4 |
Ask the chat about MEDP's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Medpace (MEDP).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.